Tim Fagan's Law

Summary

Tim Fagan's Law or the Counterfeit Drug Enforcement Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to establish a criminal fine and/or imprisonment for a person who: (1) knowingly causes a prescription drug to be adulterated, misbranded, or misrepresented as an approved prescription drug and sells or trades the drug; or (2) purchases or trades for such drug knowing or having reason to know that the drug was knowingly adulterated, misbranded, or misrepresented. Requires a manufacturer of a drug to notify the Secretary of Health and Human Services within 48 hours after first receiving or becoming aware of information that reasonably suggests that such a violation may have occurred. Deems a drug to be misbranded if it is not manufactured in accordance with the use of technologies that the Secretary determines are technically feasible and will assist in preventing such violations. Requires the Secretary to establish alternative requirements to the extent that such requirements provide greater certainty on the chain of custody and are technically feasible. Increases funding for Food and Drug Administration (FDA) inspections, examinations, and investigations. Requires the Secretary to educate the public and health care professionals on counterfeit drugs. Directs the Secretary: (1) upon a finding of reasonable probability that a drug intended for human use would cause serious health consequences or death, to issue an order requiring the appropriate person (including the manufacturers, importers, distributors, or retailers of the drug) to cease distribution of the drug and to notify and instruct health professionals to cease administering or prescribing the drug; and (2) amend the order to include a recall if necessary.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 12 May 2005

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 12 May 2005

   Introduced

   Sponsor introductory remarks on measure. (CR E950-951)

   Source: IntroReferral

3. 12 May 2005

   Introduced

   Introduced in House

   Source: IntroReferral

4. 12 May 2005

   Introduced

   Introduced in House

   Source: IntroReferral

5. 23 May 2005

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 12 May 2005 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 12 May 2005

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 12 May 2005

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 12 May 2005

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Israel, Steve [D-NY-3] · D · Sponsor
• Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Cosponsor
• Rep. Cummings, Elijah E. [D-MD-7] · D · Cosponsor
• Rep. Watson, Diane E. [D-CA-33] · D · Cosponsor
• Rep. Jackson Lee, Sheila [D-TX-18] · D · Cosponsor
• Rep. Ackerman, Gary L. [D-NY-5] · D · Cosponsor
• Rep. Owens, Major R. [D-NY-11] · D · Cosponsor
• Rep. Davis, Danny K. [D-IL-7] · D · Cosponsor
• Rep. Higgins, Brian [D-NY-26] · D · Cosponsor
• Rep. Pastor, Ed [D-AZ-4] · D · Cosponsor
• Rep. Waxman, Henry A. [D-CA-33] · D · Cosponsor
• Rep. Woolsey, Lynn C. [D-CA-6] · D · Cosponsor
• Rep. Fattah, Chaka [D-PA-2] · D · Cosponsor
• Rep. Conyers, John, Jr. [D-MI-13] · D · Cosponsor
• Rep. Lowey, Nita M. [D-NY-17] · D · Cosponsor
• · hsif00 · Standing

Related records

• related to → Counterfeit Drug Enforcement Act
• related to ← Tim Fagan's Law